商务合作
动脉网APP
可切换为仅中文
Investment positions leading North American CRO to expand clinical research and regulatory capabilities.
投资头寸推动北美合同研究组织(CRO)扩大临床研究和监管能力。
LONDON, ON and CHICAGO
安大略省伦敦和芝加哥
,
,
July 27, 2026
2026年7月27日
/PRNewswire/ -- KGK Science Inc. ('KGK'), a leading North American contract research organization specializing in clinical trials and regulatory services for the dietary supplement, nutraceutical and consumer health industries, today announced it has received a growth investment led by Maxim Partners.
/美通社/ -- 北美领先的合同研究组织KGK Science Inc.(简称“KGK”),专注于为膳食补充剂、营养保健品和消费者健康行业提供临床试验和监管服务,今日宣布已获得由Maxim Partners领投的增长型投资。
The transaction closed on June 30, 2026. Financial terms were not disclosed..
该交易于2026年6月30日完成。财务条款未予披露。
Founded in 1997, KGK has completed more than 400 clinical trials across over 40 health indications and published more than 150 peer-reviewed scientific publications. The company provides clinical research, regulatory consulting, and claim substantiation services that help consumer health companies develop and commercialize scientifically validated products worldwide..
KGK成立于1997年,已完成涵盖40多个健康适应症的400多项临床试验,并发表了150多篇经同行评审的科学出版物。该公司提供临床研究、监管咨询和功效宣称验证服务,助力消费健康企业在全球范围内开发并商业化经科学验证的产品。
The investment will support expanded clinical trial capacity, continued investment in
这笔投资将支持扩大临床试验能力,并继续投资于
decentralized
去中心化
and virtual trial capabilities, growth of KGK's regulatory services, and continued expansion of its commercial organization. Founder and CEO Najla Guthrie and the existing management team will continue to lead the business.
以及虚拟试验能力、KGK监管服务业务的增长,及其商业组织的持续扩张。创始人兼首席执行官Najla Guthrie与现有管理团队将继续领导公司业务。
'For nearly three decades, KGK has been committed to helping consumer nutrition companies generate the scientific evidence needed to bring innovative products to market. This investment marks an exciting new chapter for our company. Maxim shares our long-term vision and brings the strategic resources and sector experience to help us expand our capabilities, invest in our team, and better serve our clients around the world,' said Najla Guthrie, Founder and CEO of KGK Science Inc..
“近三十年来,KGK一直致力于帮助消费者营养品公司生成将创新产品推向市场所需的科学证据。此次投资标志着我们公司开启了一个令人振奋的新篇章。Maxim与我们共享长期愿景,并带来战略资源和行业经验,帮助我们扩展能力、加大对团队的投入,并更好地服务全球客户。”KGK Science Inc.创始人兼首席执行官Najla Guthrie表示。
'KGK has built a differentiated platform with an outstanding reputation for scientific rigor, regulatory expertise, and customer service. As demand for clinically validated consumer nutrition products continues to grow, we believe KGK is exceptionally well positioned to capitalize on those long-term industry trends.
KGK已打造出一个差异化平台,凭借科学严谨性、监管专业知识和客户服务赢得了卓越声誉。随着对经临床验证的消费类营养产品需求持续增长,我们认为KGK在把握这些长期行业趋势方面具备显著优势。
We are excited to partner with Najla and the management team to support the company's next phase of growth,' said Gregg Wilson, Founder & Managing Partner of Maxim Partners..
“我们很高兴与Najla和管理团队合作,支持公司下一阶段的成长。”Maxim Partners的创始人兼管理合伙人Gregg Wilson表示。
MLT Aikins (
MLT Aikins(
www.mltaikins.com
www.mltaikins.com
) was the legal advisor to Maxim Partners on the transaction.
)担任马克西姆合伙公司在该交易中的法律顾问。
About KGK Science
关于KGK科学
Founded in 1997 and headquartered in London, Ontario, KGK Science Inc. is a full-service contract research organization specializing in the nutraceutical and natural health products industry. KGK designs and conducts human clinical trials, provides regulatory and claim substantiation expertise, and supports preclinical development, giving consumer health brands the evidence they need to differentiate their products and reach global markets with confidence.
KGK Science Inc. 成立于1997年,总部位于安大略省伦敦市,是一家全方位服务的合同研究组织,专注于营养保健品和天然健康产品行业。KGK 设计并开展人体临床试验,提供监管合规与功效宣称证实方面的专业知识,并支持临床前开发,为消费者健康品牌提供必要的证据,以帮助其产品实现差异化,并自信地进军全球市场。
For more information, visit .
更多信息,请访问。
kgkscience.com
kgkscience.com
.
。
About Maxim Partners
关于 Maxim Partners
Maxim Partners is a Chicago-based investment firm dedicated to backing founders and managers seeking to impact lives through nutrition, nutraceuticals, functional foods, fitness, recreation, pets, personal care, and education. Maxim helps entrepreneurial leaders accelerate growth through capital, operational support, and deep sector expertise.
Maxim Partners 是一家总部位于芝加哥的投资公司,致力于支持那些希望通过营养、营养保健品、功能性食品、健身、休闲、宠物、个人护理和教育等领域影响人们生活的创始人和管理者。Maxim 通过提供资金、运营支持和深厚的行业专业知识,帮助创业领导者加速增长。
For more information, visit .
更多信息,请访问。
www.maximpartnersllc.com
www.maximpartnersllc.com
.
。
SOURCE Maxim Partners
来源 Maxim Partners
21
二十一
%
%
more press release views with
更多新闻稿浏览量,通过
Request a Demo
申请演示